Jean-Charles Nault received his MD and PhD from Paris Descartes University. He is currently working as an associate professor in the liver unit of the Avicenne Hospital in Bobigny, France. He is also an active member of the laboratory of “functional genomics of solid tumors” at the INSERM UMR 1138 in Cordeliers Research Center.
He had an expertise in organization of scientific events (organization of the ILCA school 2020, Liver Cancer Summit 2021) as a member of the guidelines of hepatocellular carcinoma for the European Society For Medical Oncology and as a member of the governing board of the International liver cancer association. He is also involved in EASL activities as an active member of the society, as an awardee of the Young Investigator Award of EASL in 2017, as an associate editor in Journal Of Hepatology and as a past member of the young investigator task forces.
His research is dedicated to translational and clinical research in primary liver tumors. The main topics of his work are the identification of new driver genes in hepatocellular adenoma and hepatocellular carcinoma, of new therapeutic targets and of the molecular determinants of hepatocellular carcinoma’s prognosis.